ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1064

Test-retest Reliability for the Mawdsley Calcinosis Questionnaire for the Measurement of Calcinosis Burden in Patients with Systemic Sclerosis

Antonia Valenzuela1, Anne-Marie Russell2, Lorinda Chung3, Kelly Jensen4 and Lesley Ann Saketkoo5, 1Pontificia Universidad Catolica de Chile, Santiago, Chile, 2University of Exeter, Exeter, United Kingdom, 3Stanford University, Stanford, CA, 4University of Colorado, Bellevue, WA, 5University Medical Center - Comprehensive Pulmonary Hypertension Center and ILD Clinic Programs // New Orleans Scleroderma and Sarcoidosis Patient Care & Research Centeris, New Orleans, LA

Meeting: ACR Convergence 2022

Keywords: calcinosis, Outcome measures

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Calcinosis cutis is a debilitating manifestation in systemic sclerosis (SSc) responsible for a high burden of disability and hand dysfunction, contributing as much as arthritis to patient physical limitations. The Mawdsley Calcinosis Questionnaire is a novel patient reported outcome measure (PROM) developed to assess the severity and impact of SSc-related calcinosis in clinical studies/clinical practice. It contains 6 items of quantification, a test question of interpretation and 3 domains: Pain/sensation (5 items); Physical Function (4 items) and Psychological Impact (6 items). We aimed to assess the test–retest reliability of this PROM in SSc patients with calcinosis.

Methods: Items for the PROM were generated from patient’s experiences of SSc-calcinosis to quantify the impact of calcinosis. Items are rated no limitation (0) to worst limitation possible (10). Items are grouped by domain and total scores. Test-retest reliability was assessed using mean absolute change and mean absolute difference and examined through paired T-tests. A global rate of change score (GCRS) was calculated at time point 2 (TP2) using a 0-10 scale. Internal reliability was assessed using the intraclass correlation coefficient (ICC). The ICC was calculated for total scores and domains using a two-way random effects model, selecting absolute agreement.

Results: All 19 respondents were SSc female patients, 5 from the United Kingdom and 14 from the United States. Mean days between completion was 16.8 days (range 14-24). In quantification of calcinosis, 9 participants scored zero at TP1 increasing to 11 at TP2 for at least one item. Median score of feeling certain lesion is calcinosis at TP1 =5 (range 0-80) and TP2=5 (range 0-100). The mean, mean scores, mean change, mean absolute difference for domains and total scores at TP1 and TP2 are presented in table 1. All p values associated with the T- test were >0.05 indicating that there were no significant differences between scores at TP1 and TP2 (good stability). The mean GRCS was 2 (range 1-3) indicating no significant change on calcinosis burden within 2 weeks. ICC values were > 0.5 suggesting moderate reliability in this small cohort.

Conclusion: The Mawdsley Calcinosis Questionnaire demonstrated a good stability. The test-retest reliability was moderate. This may be due to the heterogeneity in this small group of SSc patients with calcinosis. Recruitment is continuing. Next steps are to perform factor analysis to evaluate how items fit the domains, and correlations with Raynaud phenomenon, digital ulcers, and how well this correlated with other PROMs, such as the Cochin Hand Function Scale, SHAQ and SF-36.

Supporting image 1


Disclosures: A. Valenzuela, None; A. Russell, None; L. Chung, Kyverna, Mitsubishi Tanabe, Eicos, Boehringer-Ingelheim, Jasper, Genentech; K. Jensen, None; L. Saketkoo, None.

To cite this abstract in AMA style:

Valenzuela A, Russell A, Chung L, Jensen K, Saketkoo L. Test-retest Reliability for the Mawdsley Calcinosis Questionnaire for the Measurement of Calcinosis Burden in Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/test-retest-reliability-for-the-mawdsley-calcinosis-questionnaire-for-the-measurement-of-calcinosis-burden-in-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/test-retest-reliability-for-the-mawdsley-calcinosis-questionnaire-for-the-measurement-of-calcinosis-burden-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology